Dr. Nasser Khan is Acadia’s Chief Operating Officer (COO). In this role, Dr. Khan oversees the entirety of our operational functions – including quality and clinical operations, facility operations and admissions – to ensure we deliver against our patient care and growth objectives.

Dr. Khan joined Acadia in 2022 as Group President of our Comprehensive Treatment Centers (CTC). Under his leadership, the CTC business grew significantly, adding 11 new de novo clinics and mobile vans and increasing patient retention. Dr. Khan is a passionate advocate for talent – recruiting strong leaders and increasing CTC employee retention. During his tenure as Group President, he maintained the highest-level standards for care as evidenced by delivering best-in-class quality scores of 99% across all 13 dimensions measured by the international regulatory body, CARF.

Dr. Khan joined Acadia from Shields Health Solutions, a national provider of specialty pharmacy services to health systems and a subsidiary of Walgreens Boots Alliance, Inc., where he served as Senior Vice President, Operations. Prior to Shields, he served as Head of Program and Chief Medical Officer at Biograph Inc., a healthcare technology company. He also held a series of progressive operational leadership roles at DaVita, Inc. Earlier in his career, Dr. Khan was an Engagement Manager in the healthcare practice at McKinsey & Company.

Dr. Khan holds a Doctor of Medicine (M.D.), a Master of Medical Science (M.M.S.) and a Bachelor of Arts in Human Biology from Brown University where he graduated magna cum laude.